p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis: MRI Assessment
暂无分享,去创建一个
R. Mirabile | R. Willette | R. Boyce | B. Jucker | K. Aravindhan | A. Olzinski | R. Bernard | Joanne B. Morris | Rosanna Mirabile | Alan R. Olzinski
[1] W. Bao,et al. Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production , 2007, Journal of cardiovascular pharmacology.
[2] Li Wang,et al. TLR2 and TLR4 agonists synergistically up-regulate SR-A in RAW264.7 through p38. , 2007, Molecular immunology.
[3] Zahi A Fayad,et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI , 2007, Proceedings of the National Academy of Sciences.
[4] Ralph Weissleder,et al. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis , 2006, Circulation.
[5] Florian M Vogt,et al. Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide , 2006, Journal of magnetic resonance imaging : JMRI.
[6] J. Gillard,et al. Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[7] R. Weissleder,et al. Cellular Imaging of Inflammation in Atherosclerosis Using Magnetofluorescent Nanomaterials , 2006, Molecular imaging.
[8] C. Wanner,et al. Impact of oxidized low density lipoprotein on vascular cells. , 2006, Atherosclerosis.
[9] Fabien Hyafil,et al. Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Willette,et al. Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling , 2005, Journal of magnetic resonance imaging : JMRI.
[11] D. Behm,et al. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection. , 2005, Cardiovascular research.
[12] Lufei Hu,et al. Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice. , 2005, American journal of hypertension.
[13] M. Linton,et al. Angiotensin II Amplifies Macrophage-Driven Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[14] A. Daugherty,et al. Angiotensin II-mediated development of vascular diseases. , 2004, Trends in cardiovascular medicine.
[15] Ryan M. O’Connell,et al. Toll-like Receptors Induce a Phagocytic Gene Program through p38 , 2004, The Journal of experimental medicine.
[16] Isabelle Raynal,et al. Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.
[17] D. Behm,et al. p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 1. p38 MAPK-Dependent Endothelial Dysfunction and Hypertension , 2003, Journal of Pharmacology and Experimental Therapeutics.
[18] Juan Jiménez,et al. Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. , 2003, Blood.
[19] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[20] T. Nakao,et al. Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene Expression , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[21] M. Naghavi,et al. Superparamagnetic Iron Oxide–Based Method for Quantifying Recruitment of Monocytes to Mouse Atherosclerotic Lesions In Vivo: Enhancement by Tissue Necrosis Factor-&agr;, Interleukin-1&bgr;, and Interferon-&ggr; , 2003, Circulation.
[22] A. Daugherty,et al. Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II–Induced Atherosclerosis and Abdominal Aortic Aneurysms , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[23] A. Brasier,et al. Vascular inflammation and the renin-angiotensin system. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[24] John C. Lee,et al. Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. , 2002, The Journal of pharmacology and experimental therapeutics.
[25] V. Schmithorst,et al. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. , 2001, Magnetic resonance imaging.
[26] B Hamm,et al. Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles , 2001, Journal of magnetic resonance imaging : JMRI.
[27] John C. Lee,et al. Hypertensive End-Organ Damage and Premature Mortality Are p38 Mitogen-Activated Protein Kinase–Dependent in a Rat Model of Cardiac Hypertrophy and Dysfunction , 2001, Circulation.
[28] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[29] S. Schmitz,et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. , 2000, Investigative radiology.
[30] A Daugherty,et al. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.
[31] W Kübler,et al. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[32] Z. Brown,et al. p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.
[33] R. Alexander,et al. p38 Mitogen-activated Protein Kinase Is a Critical Component of the Redox-sensitive Signaling Pathways Activated by Angiotensin II , 1998, The Journal of Biological Chemistry.
[34] C Zimmer,et al. MR imaging of phagocytosis in experimental gliomas. , 1995, Radiology.